文献速递关节外科

加巴喷丁类药物在全关节置换术中的疗效与安全性:系统综述与直接荟萃分析

The Efficacy and Safety of Gabapentinoids in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2020-05-26

本研究通过系统综述与直接荟萃分析评估加巴喷丁类药物在初次全关节置换术中的疗效与安全性,共纳入13项高质量研究。结果显示,普瑞巴林在出院后能减少术后疼痛和阿片类药物消耗,但加巴喷丁无效;围手术期普瑞巴林仅减少阿片消耗而不减轻疼痛。中等证据支持普瑞巴林用于全关节置换术,但需警惕镇静和呼吸抑制风险。

要点

  • 普瑞巴林在出院后减少术后疼痛和阿片消耗,加巴喷丁无此效果。
  • 围手术期普瑞巴林减少阿片消耗但不减轻疼痛。
  • 加巴喷丁类药物可能增加镇静和呼吸抑制风险,尤其与阿片类联用时需谨慎。

核心结论

  • 中等证据支持全关节置换术中使用普瑞巴林以减少术后疼痛和阿片类药物消耗。
  • 加巴喷丁类药物应谨慎使用,因其可能增加镇静和呼吸抑制风险,尤其与阿片类等中枢神经系统抑制剂联用时。

主要发现

  • 围手术期至出院前,普瑞巴林减少术后阿片类药物消耗,但加巴喷丁类药物不减轻术后疼痛。
  • 出院后,加巴喷丁不减少术后疼痛或阿片消耗,而普瑞巴林两者均减少。

临床怎么用

  • 可考虑在全关节置换术围手术期及出院后使用普瑞巴林以减少阿片消耗和术后疼痛。
  • 使用加巴喷丁类药物时应警惕镇静和呼吸抑制风险,尤其与阿片类联用时。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gabapentinoids are commonly used as an adjunct to traditional pain management strategies after total joint arthroplasty (TJA). The purpose of this study is to evaluate the efficacy and safety of gabapentinoids in primary TJA to support the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and the American Society of Regional Anesthesia and Pain Management. METHODS: The MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials were searched for studies published prior to November 2018 on gabapentinoids in TJA. All included studies underwent qualitative and quantitative homogeneity testing followed by a systematic review and direct comparison meta-analysis to assess the efficacy and safety of gabapentinoids. RESULTS: In total, 384 publications were critically appraised to provide 13 high-quality studies regarded as the best available evidence for analysis. In the perioperative period prior to discharge, pregabalin reduces postoperative opioid consumption, but gabapentinoids do not reduce postoperative pain. After discharge, gabapentin does not reduce postoperative pain or opioid consumption, but pregabalin reduces both postoperative pain and opioid consumption. CONCLUSION: Moderate evidence supports the use of pregabalin in TJA to reduce postoperative pain and opioid consumption. Gabapentinoids should be used with caution, however, as they may lead to an increased risk of sedation and respiratory depression especially when combined with other central nervous system depressants such as opioids.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hannon CP, Fillingham YA, Browne JA, et al. The Efficacy and Safety of Gabapentinoids in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis. J Arthroplasty. 2020. PMID: 32586656. doi:10.1016/j.arth.2020.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。